| Literature DB >> 35706562 |
Jessica M May1, Monal Depani1, Andrew M Ferry2,3, John C Koshy2,3, James F Thornton1.
Abstract
The indications for using biologic wound agents have expanded greatly since first being employed for acute burn management. The majority of the literature details the use of said agents in the adult population; however, there is little representation regarding their uses for reconstructing defects typically observed in the pediatric population. Ironically, children, and to a lesser extent adolescents, greatly benefit from their use given the reduced skin laxity and amount of surrounding tissue available for locoregional tissue transfer when compared with adults. Herein, we detail the use of acellular and cellular biologic wound agents in the pediatric population. Thieme. All rights reserved.Entities:
Keywords: AlloDerm; Integra; TheraSkin; biologic wound agents; pediatrics; plastic surgery; wound healing
Year: 2022 PMID: 35706562 PMCID: PMC9192154 DOI: 10.1055/s-0042-1742748
Source DB: PubMed Journal: Semin Plast Surg ISSN: 1535-2188 Impact factor: 2.195